Recent Finacing
Recent Raise
Elcelyx Therapeutics develops gut-targeted therapies including delayed-release metformin NewMet (Metformin DR) and Lovidia dietary formulations, advancing late-stage clinical programs for weight management and type 2 diabetes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
